BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 12835671)

  • 1. Curing metastatic cancer: lessons from testicular germ-cell tumours.
    Masters JR; Köberle B
    Nat Rev Cancer; 2003 Jul; 3(7):517-25. PubMed ID: 12835671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy for metastatic germ cell tumours of the testis].
    Culine S
    Rev Prat; 2007 Feb; 57(4):385-8. PubMed ID: 17455740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrovascular accident during cisplatin-based combination chemotherapy of testicular germ cell tumor: an unusual case report.
    Azak A; Oksüzoğlu B; Deren T; Oneç BM; Zengin N
    Anticancer Drugs; 2008 Jan; 19(1):97-8. PubMed ID: 18043135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular events in germ cell tumours: linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin.
    Korkola JE; Houldsworth J; Bosl GJ; Chaganti RS
    BJU Int; 2009 Nov; 104(9 Pt B):1334-8. PubMed ID: 19840009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medical treatment of metastatic germ cell cancers].
    Timsit MO; Lebret T; Lugagne PM; Méjean A
    Prog Urol; 2008 Nov; 18 Suppl 7():S376-81. PubMed ID: 19070818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth and chemotherapy of a human germ-cell tumour line (GCT 27).
    Schlappack OK; Bush C; Delic JI; Steel GG
    Strahlenther Onkol; 1989 Jul; 165(7):541. PubMed ID: 2473535
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of recurrent metastatic testicular cancer, successfully treated with paclitaxel, ifomide and cisplatin].
    Yanada S; Ito H; Tomita M; Wada T; Hatano T; Kishimoto K; Egawa S
    Hinyokika Kiyo; 2008 Jan; 54(1):43-6. PubMed ID: 18260360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carboplatin-etoposide-bleomycine chemotherapy protocol in the treatment of patients with metastatic non-seminomatous germ-cell testicular tumours with good prognosis].
    Jeremić B; Djurić Lj; Djordjević S; Cirović V; Milojević Lj; Stanisavljević B; Matović M; Mijatović Lj
    Srp Arh Celok Lek; 1994; 122(9-10):257-9. PubMed ID: 17977429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for good-risk germ cell tumors: current concepts and controversies.
    Vaughn DJ
    Urol Clin North Am; 2007 May; 34(2):171-7; abstract viii-ix. PubMed ID: 17484922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current management of stage I testicular non-seminomatous germ cell tumours.
    Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
    Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in management of patients with platinum-refractory testicular germ cell tumors.
    Kollmannsberger C; Nichols C; Bokemeyer C
    Cancer; 2006 Mar; 106(6):1217-26. PubMed ID: 16463389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cisplatin in the treatment of testicular carcinoma].
    van Groeningen CJ; Pinedo HM
    Ned Tijdschr Geneeskd; 1986 Nov; 130(44):1980-4. PubMed ID: 3022163
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
    J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of nodal metastases after chemotherapy in nonseminomatous testis cancer: a possible indication for limited dissection.
    Ehrlich Y; Yossepowitch O; Kedar D; Baniel J
    BJU Int; 2006 Jun; 97(6):1221-4. PubMed ID: 16686715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.
    Marwaha S; Venner PM; North SA
    Can J Urol; 2007 Oct; 14(5):3692-6. PubMed ID: 17949524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of chemotherapy in germ cell tumours.
    Kaye SB; Boyle P
    Cancer Surv; 1989; 8(3):631-46. PubMed ID: 2561756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy for stage II nonseminomatous germ cell tumors.
    Kondagunta GV; Motzer RJ
    Urol Clin North Am; 2007 May; 34(2):179-85; abstract ix. PubMed ID: 17484923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the blood-brain barrier relevant in metastatic germ cell tumor?
    Azar JM; Schneider BP; Einhorn LH
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):163-6. PubMed ID: 17707269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
    Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.